About Us
Background
ACTM's Scientific Director, Dr. Greg Korbutt was a member of the original Edmonton Protocol team that developed a successful islet cell transplant protocol to treat Type 1 diabetes. Building upon this early success, Dr. Korbutt received 26.2 million dollars in funding from the , and the ß÷ßäÉçÇø to build a state-of-art GMP cleanroom facility to support cell-based therapy manufacturing for all diseases and conditions that may be targeted by these innovative treatments. With construction complete in 2014, ACTM became the only facility of its kind in Western Canada and offers its services to researchers and industry worldwide.
Our Mission
ß÷ßäÉçÇø Cell Therapy Manufacturing delivers high-quality and innovative cell-based
therapy and aseptic fill-finish services to clients in need by providing customized
solutions and support throughout the product lifecycle at a competitive cost.
Our Values
Quality: We commit to excellence and continually improve processes to deliver the
highest standard of products and services.
Integrity: We act with honesty, transparency, and ethical focus in all relationships and
decisions.
Compliance: We ensure clients and staff are equipped to meet or surpass all
relevant regulatory and accreditation standards.
Collaboration: We work closely with academic, clinical, public, and commercial
partners to drive shared success and innovation.
Client-Driven: We provide accessible, personalized guidance and cultivate long-term
partnerships focused on client goals.
Location
The GMP facility is located on the 7th and 8th floor of the Li Ka Shing Centre for Health Research Innovation in Edmonton, ß÷ßäÉçÇø, Canada.
Centered within the ß÷ßäÉçÇø's Faculty of Medicine and located next to the ß÷ßäÉçÇø Hospital, ACTM is well situate d to interact with these research-intensive institutions in order to support manufacture and preparation of clinical and approved therapies. Our close proximity to the Edmonton International Airport enables efficient deliveries to and from our facility.
Our Team
Greg Korbutt, PhD - Scientific Director
5-002D Li Ka Shing Centre for Health Research Innovation
ß÷ßäÉçÇø, Edmonton, ß÷ßäÉçÇø T6G 2E1
Gayle Piat - ACTM Manager
RQAP-GLP, RAC 7-002 Li Ka Shing Centre for Health Research Innovation
ß÷ßäÉçÇø, Edmonton, ß÷ßäÉçÇø T6G 2E1